Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Recruiting
5,950 enrolled
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Recruiting
950 enrolled
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Recruiting
1,130 enrolled
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Recruiting
6,035 enrolled
FIT-001
Phase 1 Recruiting
300 enrolled
Rein3DP-M
Phase NA Recruiting
50 enrolled
RCCETT
Recruiting
4,700 enrolled
NEOPAX
Phase 2 Recruiting
17 enrolled
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/2 Recruiting
126 enrolled
Kidney Cancer DNA Registry
Recruiting
750 enrolled
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
Phase 1/2 Recruiting
100 enrolled
STEALTH-001
Phase 1 Recruiting
60 enrolled
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Phase 1 Recruiting
125 enrolled
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Phase 1/2 Recruiting
224 enrolled
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
Phase 1 Recruiting
35 enrolled
NEPHRAMBU
Recruiting
50 enrolled
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Phase 2 Recruiting
10 enrolled
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 3 Recruiting
720 enrolled
LUTEON
Phase 3 Recruiting
40 enrolled
PP-RECURK
Recruiting
105 enrolled
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Recruiting
5,000 enrolled
ORCHID
Phase 2 Recruiting
20 enrolled
ARC-20
Phase 1 Recruiting
362 enrolled
SPARCC
Phase 2 Recruiting
25 enrolled
NAMECAR
Phase NA Recruiting
60 enrolled
Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
Phase 2 Recruiting
32 enrolled
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Recruiting
300 enrolled
MetroWilms
Phase 1/2 Recruiting
28 enrolled
64Cu-GRIP B in Patients With Advanced Malignancies
Phase 1/2 Recruiting
91 enrolled
Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
Phase 2 Recruiting
148 enrolled
68Ga-PSMA PET in the Renal Cell Carcinoma
Phase NA Recruiting
300 enrolled
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
30 enrolled
DISSRM
Recruiting
600 enrolled
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Phase 1 Recruiting
307 enrolled
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Phase 1 Recruiting
140 enrolled
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Phase 2 Recruiting
87 enrolled
OCCURORTW
Recruiting
2,000 enrolled
VERDI
Phase NA Recruiting
1,020 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
BASECAMP-1
Recruiting
200 enrolled
WASHOUT
Recruiting
1,050 enrolled
SMILe
Phase 3 Recruiting
220 enrolled
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Phase NA Recruiting
600 enrolled
COSTAR
Recruiting
300 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
iCaRe2
Recruiting
999,999 enrolled
TAGNOT
Phase 1/2 Recruiting
58 enrolled
Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial
Recruiting
53 enrolled
CAMPERR
Recruiting
7,000 enrolled